Osteoporosis

15 competing products in clinical development for Osteoporosis.

Pipeline by Phase

Pre-clinical1
Phase 11
Phase 23
Phase 2/31
Phase 36
Approved3

All Products (15)

ProductCompanyStageStatusHype
raloxifene + placeboEli LillyApprovedCompleted
43
MENATETRANONEEisaiApprovedCompleted
43
Menatetrenone (Vitamin K2)EisaiApprovedCompleted
43
Teriparatide + Alendronate Sodium + Placebo + PlaceboEli LillyPhase 3Completed
40
TeriparatideEli LillyPhase 3Completed
40
Teriparatide + Salmon CalcitoninEli LillyPhase 3Completed
40
ED-71 + Alfacalcidol + ED-71 placebo + Alfacalcidol placeboChugai PharmaceuticalPhase 3Completed
40
Denosumab + Placebo + Alendronate sodium hydrateDaiichi SankyoPhase 3Completed
40
phylloquinone (K1) + menatetranone (MK4)EisaiPhase 3Completed
40
YM529 / ONO-5920Astellas PharmaPhase 2/3Completed
38
Subcutaneous Teriparatide + Transdermal TeriparatideEli LillyPhase 2Completed
35
arzoxifene + PlaceboEli LillyPhase 2Completed
35
ONO-5334 + ONO-5334 + ONO-5334 + ONO-5334 + ONO-5334Ono PharmaceuticalPhase 2Completed
35
ONO-5920 / YM529Astellas PharmaPhase 1Completed
29
ForteoEli LillyPre-clinicalUNKNOWN
22